Perritt Capital Management’s ImmuCell ICCC Stock Holding History

Perritt Capital Management’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,026	Closed	-$144K	–	344
2023 Q3	$144K	Hold	27,026	–	–	0.08%	160
2023 Q2	$135K	Sell	27,026 -2,649	-9%	-$13.6K	0.07%	171
2023 Q1	$152K	Sell	29,675 -325	-1%	-$2.11K	0.08%	163
2022 Q4	$183K	Sell	30,000 -6,494	-18%	-$46.9K	0.1%	158
2022 Q3	$273K	Hold	36,494	–	–	0.17%	127
2022 Q2	$317K	Hold	36,494	–	–	0.19%	126
2022 Q1	$352K	Sell	36,494 -3,506	-9%	-$30.3K	0.19%	125
2021 Q4	$320K	Sell	40,000 -10,000	-20%	-$89.3K	0.17%	141
2021 Q3	$468K	Hold	50,000	–	–	0.26%	109
2021 Q2	$475K	Sell	50,000 -5,000	-9%	-$48.8K	0.25%	116
2021 Q1	$530K	Hold	55,000	–	–	0.29%	98
2020 Q4	$327K	Sell	55,000 -5,000	-8%	-$29.1K	0.2%	127
2020 Q3	$326K	Hold	60,000	–	–	0.24%	114
2020 Q2	$284K	Sell	60,000 -10,000	-14%	-$43.6K	0.21%	122
2020 Q1	$265K	Sell	70,000 -26,900	-28%	-$132K	0.22%	125
2019 Q4	$499K	Sell	96,900 -23,100	-19%	-$119K	0.24%	119
2019 Q3	$668K	Sell	120,000 -10,000	-8%	-$58.5K	0.28%	105
2019 Q2	$845K	Sell	130,000 -23,000	-15%	-$146K	0.33%	93
2019 Q1	$972K	Sell	153,000 -1,300	-0.8%	-$9.28K	0.36%	82
2018 Q4	$1.09M	Hold	154,300	–	–	0.42%	73
2018 Q3	$1.28M	Hold	154,300	–	–	0.39%	77
2018 Q2	$1.05M	Hold	154,300	–	–	0.31%	93
2018 Q1	$1.25M	Hold	154,300	–	–	0.36%	86
2017 Q4	$1.36M	Buy	154,300 +20,500	+15%	+$168K	0.38%	84
2017 Q3	$870K	Buy	133,800 +2,859	+2%	+$18.7K	0.23%	124
2017 Q2	$960K	Buy	130,941 +7,427	+6%	+$44.1K	0.25%	113
2017 Q1	$683K	Buy	123,514 +23,514	+24%	+$135K	0.17%	137
2016 Q4	$595K	Buy	100,000 +17,371	+21%	+$106K	0.14%	134
2016 Q3	$639K	Buy	82,629 +50	+0.1%	+$364	0.16%	136
2016 Q2	$570K	Hold	82,579	–	–	0.15%	141
2016 Q1	$566K	Buy	+82,579	New	+$551K	0.14%	141

Other funds holding ICCC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OMC

Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return

Perritt Capital Management's ICCC Position: Q4 2023 in Review

Perritt Capital Management sold out of ImmuCell (ICCC) in Q4 2023, closing a stake of 27,026 shares — an estimated $144K sold.

Perritt Capital Management first reported a position in ICCC in Q1 2016 and held it in 31 quarters. The position peaked at $1.36M in Q4 2017. 28 funds tracked by Wall St. Rank hold ICCC as of Q4 2023.

Perritt Capital Management reported no remaining ImmuCell position as of Q4 2023 after selling out during the quarter.
Perritt Capital Management sold 27,026 ImmuCell shares in Q4 2023, an estimated $144K.
Perritt Capital Management first reported a position in ImmuCell in Q1 2016 and held it in 31 quarters.
Perritt Capital Management's ImmuCell position peaked at $1.36M in Q4 2017.
28 funds tracked by Wall St. Rank held ImmuCell as of Q4 2023.

Based on Perritt Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.